AGA Rapid Clinical Practice Update on the Management of Patients Taking GLP-1 Receptor Agonists Prior to Endoscopy: Communication
- PMID: 37944573
- DOI: 10.1016/j.cgh.2023.11.002
AGA Rapid Clinical Practice Update on the Management of Patients Taking GLP-1 Receptor Agonists Prior to Endoscopy: Communication
Abstract
Description: The purpose of this American Gastroenterological Association (AGA) Institute Rapid Clinical Practice Update (CPU) Communication is to review the available evidence and provide expert advice regarding the evolving management of patients taking GLP-1 receptor agonists prior to endoscopy.
Methods: This CPU was commissioned and approved by the AGA Institute Clinical Practice Updates Committee (CPUC) and the AGA Governing Board to provide timely guidance on a topic of high clinical importance to the AGA membership and underwent internal peer review by the CPUC and external peer review through standard procedures of Clinical Gastroenterology and Hepatology. This communication incorporates important and recently published studies in this field, and it reflects the experiences of the authors who are experts in bariatric medicine and/or endoscopy.
Keywords: Anesthesia; Glucagon-like peptide; Ozempic; Sedation; Semaglutide; Wegovy.
Copyright © 2024 AGA Institute. Published by Elsevier Inc. All rights reserved.
Similar articles
-
AGA Clinical Practice Update on Telemedicine in Gastroenterology: Commentary.Gastroenterology. 2023 Apr;164(4):690-695. doi: 10.1053/j.gastro.2022.12.043. Epub 2023 Feb 10. Gastroenterology. 2023. PMID: 36775722
-
AGA Clinical Practice Update on Diagnosis and Management of Cyclic Vomiting Syndrome: Commentary.Gastroenterology. 2024 Sep;167(4):804-811.e1. doi: 10.1053/j.gastro.2024.05.031. Epub 2024 Jul 16. Gastroenterology. 2024. PMID: 39023502 Review.
-
AGA Clinical Practice Update on Gastric Peroral Endoscopic Myotomy for Gastroparesis: Commentary.Gastroenterology. 2023 Jun;164(7):1329-1335.e1. doi: 10.1053/j.gastro.2023.02.027. Epub 2023 Apr 20. Gastroenterology. 2023. PMID: 37086247
-
AGA Clinical Practice Update on Diagnosis and Management of Cannabinoid Hyperemesis Syndrome: Commentary.Gastroenterology. 2024 May;166(5):930-934.e1. doi: 10.1053/j.gastro.2024.01.040. Epub 2024 Mar 5. Gastroenterology. 2024. PMID: 38456869 Review.
-
AGA Clinical Practice Update on the Diagnosis and Management of Extraesophageal Gastroesophageal Reflux Disease: Expert Review.Clin Gastroenterol Hepatol. 2023 Jun;21(6):1414-1421.e3. doi: 10.1016/j.cgh.2023.01.040. Epub 2023 Apr 14. Clin Gastroenterol Hepatol. 2023. PMID: 37061897
Cited by
-
A Scoping Review of GLP-1 Receptor Agonists: Are They Associated with Increased Gastric Contents, Regurgitation, and Aspiration Events?J Clin Med. 2024 Oct 23;13(21):6336. doi: 10.3390/jcm13216336. J Clin Med. 2024. PMID: 39518474 Free PMC article. Review.
-
Glucagon-like peptide-1 receptor agonists before upper gastrointestinal endoscopy and risk of pulmonary aspiration or discontinuation of procedure: cohort study.BMJ. 2024 Oct 22;387:e080340. doi: 10.1136/bmj-2024-080340. BMJ. 2024. PMID: 39438043 Free PMC article.
-
Confounding Factors in the Association Between Glucagon-Like Peptide-1 Receptor Agonist Use and Retained Gastric Contents in Asymptomatic Patients Undergoing Upper Gastrointestinal Endoscopy: A Retrospective Study.Cureus. 2024 Sep 11;16(9):e69152. doi: 10.7759/cureus.69152. eCollection 2024 Sep. Cureus. 2024. PMID: 39398811 Free PMC article.
-
Impact of GLP-1 Receptor Agonists in Gastrointestinal Endoscopy: An Updated Review.J Clin Med. 2024 Sep 22;13(18):5627. doi: 10.3390/jcm13185627. J Clin Med. 2024. PMID: 39337114 Free PMC article. Review.
-
Real-World Impact of GLP-1 Receptor Agonists on Endoscopic Patient Outcomes in an Ambulatory Setting: A Retrospective Study at a Large Tertiary Center.J Clin Med. 2024 Sep 12;13(18):5403. doi: 10.3390/jcm13185403. J Clin Med. 2024. PMID: 39336890 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
